Real-world comparison of CAR T-cell therapy versus bispecific antibodies in relapsed or refractory multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417009449
